Skip to main content
Online First
Editorial, COVID-19
Protecting Patients with Cancer During the COVID-19 Pandemic
Robert Mancini, PharmD, BCOP, FHOPA, Timothy G. Tyler, PharmD, FCSHP, FHOPA
Robert Mancini, PharmD, BCOP, FHOPA, and Timothy G. Tyler, PharmD, FCSHP, FHOPA
Read More
Chronic Lymphocytic Leukemia
Navigating Chronic Lymphocytic Leukemia (CLL): The Critical Importance of the First 90 Days
Read More
Editorial, HOPA Abstracts
HOP(A) Springs Eternal
Bryna Delman Ewachiw, PharmD, BCOP, Mark L. Zangardi, PharmD, BCOP
By Bryna Delman Ewachiw, PharmD, BCOP; Mark L. Zangardi, PharmD, BCOP
Read More
HOPA Abstracts, Lymphoma
A Pooled Safety Analysis of Loncastuximab Tesirine in Relapsed or Refractory DLBCL in the LOTIS Clinical Trial Program: Incidence, Onset, and Management of Myelosuppression
Abstract #CR01
Read More
HOPA Abstracts
Evaluation of Empiric Double Coverage with Tobramycin for Adult Patients with Febrile Neutropenia
Abstract #CR02
Read More
HOPA Abstracts, Gynecologic Cancers
Treatment Patterns, Real-World Outcomes, and Resource Use in Patients with Non–MSI-High or Mismatch Repair Proficient Advanced Endometrial Cancer
Abstract #CR03
Read More
HOPA Abstracts, Breast Cancer, CDK4/6 Inhibitors
Development and Implementation of a Pharmacist-Led Virtual Clinic Improve the Management of Patients with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors
Abstract #CR04
Read More
HOPA Abstracts
Impact of a Remote Oncology Clinical Pharmacist Program in 4 Community Oncology Practices
Abstract #CR05
Read More
HOPA Abstracts
Impact of PGY2 Oncology Pharmacy Residents’ Learning Experiences During the COVID-19 Pandemic
Abstract #CR06
Read More
HOPA Abstracts
Integrated Health-System Specialty Pharmacy Support in Reducing Financial Toxicity of Oral Oncolytic Therapy
Abstract #CR07
Read More
Page 56 of 198
Results 551 - 560 of 1973